Position in QNCX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$16,846
-$7,100,564 QoQ
Shares Held
834
-92.1% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#34
of 46 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 11.990407673860911.ToString("F0")%
Shared 0.ToString("F0")%
None 88.00959232613909.ToString("F0")%
Common Shares in QNCX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MORGAN STANLEY holds $15,440,401,210 across 521 Biotechnology names. QNCX ranks #415 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
43,571,633 | $2,090,131,227 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
51,828,325 | $1,435,644,595 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,188,881 | $1,423,962,911 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,319,329 | $1,019,366,352 | |
| 5 | TECH |
BIO-TECHNE Corp
|
8,532,873 | $445,927,935 | |
| 6 | MRNA |
Moderna, Inc.
|
8,471,263 | $430,340,154 | |
| 7 | ARGX |
Argenx SE
|
560,711 | $409,459,203 | |
| 8 | APLS |
Apellis Pharmaceuticals, Inc.
|
10,042,399 | $404,005,708 |
All Filings in QNCX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $16,846 | 834 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $7,117,410 | 10,623 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $1,202,940 | 3,690 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $1,419,660 | 4,302 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $14,250,684 | 53,574 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $28,686,174 | 76,701 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $1,322,612 | 8,522 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $1,278,300 | 8,522 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $1,780,800 | 8,400 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $1,908,270 | 9,087 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $2,137,408 | 9,542 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $2,181,949 | 7,249 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $3,024,528 | 9,694 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $1,498,096 | 11,759 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $60,288,634 | 226,649 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $237,419,676 | 534,729 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $1,001,977,776 | 809,352 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $2,590,651,268 | 1,026,407 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $627,925,996 | 34,253 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $377,095,000 | 35,575 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $154,467,816 | 21,436 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $897,844,044 | 161,599 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $124,590,000 | 12,459 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $133,529,200 | 14,420 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $94,221,138 | 10,329 | Shares | Defined | 2020-05-26 | |
| No filing history on record for this holder in this stock. | ||||||